
Biofrontera AG BFRA
Biofrontera AG DIO Ratio 2011-2026 | BFRA
Annual DIO Ratio Biofrontera AG
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 482 | 304 | 261 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 482 | 261 | 349 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aclaris Therapeutics
ACRS
|
42.1 | $ 3.01 | 3.79 % | $ 233 M | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
12 | $ 1.09 | -2.25 % | $ 5.94 M | ||
|
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
Berkeley Lights
BLI
|
246 | - | -7.31 % | $ 87 M | ||
|
bluebird bio
BLUE
|
125 | - | - | $ 546 M | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
132 | $ 26.71 | -1.07 % | $ 1.29 B | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
247 | $ 9.6 | 0.52 % | $ 141 M | ||
|
Arena Pharmaceuticals
ARNA
|
160 | - | -6.81 % | $ 3.04 B | ||
|
Axon Enterprise
AXON
|
116 | $ 570.58 | -0.27 % | $ 43.2 B | ||
|
Catalyst Biosciences
CBIO
|
410 | $ 11.67 | 0.56 % | $ 768 M | ||
|
Aytu BioScience
AYTU
|
209 | $ 2.58 | 1.18 % | $ 16.2 M | ||
|
AstraZeneca PLC
AZN
|
206 | $ 92.13 | -0.41 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
ChromaDex Corporation
CDXC
|
114 | - | -0.88 % | $ 598 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
239 | $ 11.36 | -2.41 % | $ 735 M | ||
|
Biogen
BIIB
|
394 | $ 176.12 | -0.16 % | $ 25.6 B |